Hemodynamic Monitoring and Cardiovascular Support
Hemodynamic monitoring and cardiovascular support is the area of critical care concerned with measuring the function of the circulation and intervening to maintain adequate tissue perfusion in critically ill patients. It links the measurement of pressures, flows, and indicators of perfusion to the use of fluids, vasoactive drugs, and mechanical devices that restore circulatory adequacy in states of shock.
Definition
Hemodynamic monitoring is the measurement and serial assessment of cardiovascular variables — such as arterial pressure, cardiac output, filling pressures, and markers of tissue perfusion — used to characterize circulatory states; cardiovascular support comprises the pharmacological and mechanical interventions used to restore or sustain adequate perfusion.
Scope
The area spans the monitoring techniques used to assess the circulation in critical illness — from non-invasive measures and arterial and central venous catheters to the pulmonary artery catheter and dynamic indices — and the supportive interventions that follow, including vasopressor and inotropic therapy, mechanical circulatory support devices, and extracorporeal membrane oxygenation. It also frames the clinical syndromes, especially cardiogenic and other forms of shock, that these tools are used to characterize and treat. It is presented as a reference orientation to the field, not as bedside guidance.
Sub-topics
Core questions
- How is the adequacy of the circulation measured in a critically ill patient?
- When do monitoring data justify fluids, vasoactive drugs, or mechanical support?
- How are the major forms of shock distinguished and characterized hemodynamically?
- What is the evidence base for invasive monitoring and for each class of circulatory support?
Key concepts
- Tissue perfusion and oxygen delivery
- Cardiac output and stroke volume
- Preload, afterload, and contractility
- Mean arterial pressure and perfusion pressure
- Shock and its hemodynamic classification
- Fluid responsiveness
- Vasopressor and inotropic support
- Mechanical circulatory support and ECMO
Mechanisms
Circulatory function is governed by the interaction of cardiac output (the product of heart rate and stroke volume) and systemic vascular resistance, which together determine arterial pressure and, with it, the perfusion pressure available to organs. Shock arises when oxygen delivery fails to meet tissue demand, whether because of pump failure (cardiogenic), volume loss (hypovolemic), vasodilation (distributive), or obstruction to flow (obstructive). Monitoring aims to identify which mechanism predominates by measuring filling pressures, flow, and perfusion markers; support then targets the deranged component — restoring preload with fluids, raising tone with vasopressors, augmenting contractility with inotropes, or substituting for the heart and lungs with mechanical devices.
Clinical relevance
The concepts in this area underlie how circulatory failure is recognized and characterized in intensive care, and they organize the evidence on monitoring and support that clinicians appraise. The entry describes how the field measures and conceptualizes the circulation; it is a reference orientation and not a source of diagnostic thresholds or treatment instructions.
Epidemiology
Shock states are among the most common reasons for intensive care admission and carry high mortality; cardiogenic shock complicating myocardial infarction and septic (distributive) shock are leading contributors. The intensity of monitoring and the use of advanced support vary widely between settings and have shifted over time as trial evidence has accumulated.
Evidence & guidelines
Randomized trials have repeatedly reshaped practice in this area — for example, comparisons of vasopressor agents in shock (De Backer et al., 2010) and consensus efforts such as the SCAI shock classification (Baran et al., 2019). The Surviving Sepsis Campaign guidelines (Evans et al., 2021) and society heart-failure and acute-coronary guidelines synthesize this evidence into recommendations, while reviews such as Vincent and De Backer (2013) frame the underlying physiology.
History
The modern field grew from the introduction of bedside flow-directed pulmonary artery catheterization in 1970, which made cardiac output and filling pressures measurable at the bedside, and from later trials that questioned the routine use of such invasive monitoring. Pharmacological and mechanical support evolved in parallel, and consensus frameworks for classifying shock emerged to standardize description and comparison.
Debates
- How much invasive monitoring improves outcomes
- Trials of routine pulmonary artery catheterization did not show a survival benefit, shifting practice toward selective and less invasive monitoring and prompting ongoing debate about when invasive measurement changes management.
Key figures
- Jean-Louis Vincent
- Daniel De Backer
- Judith Hochman
Related topics
Seminal works
- vincent-2013
- debacker-2010
- baran-2019-scai
Frequently asked questions
- What is the difference between hemodynamic monitoring and cardiovascular support?
- Monitoring is the measurement of circulatory variables to assess perfusion, while cardiovascular support is the set of interventions — fluids, vasoactive drugs, and mechanical devices — used to restore adequate perfusion based on that assessment.
- Why are there different types of shock?
- Shock is classified by the dominant mechanism of circulatory failure — cardiogenic, hypovolemic, distributive, or obstructive — because each calls for a different conceptual target for monitoring and support.